Articles by Disease (Glioma)

Melatonin Attenuates Methamphetamine-Induced Neurotoxicity

Journal: Current Pharmaceutical Design
Volume: 22
Page: 1022-1032
Author(s): Pawaris Wongprayoon and Piyarat Govitrapong

Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches

Journal: Current Pharmaceutical Design
Volume: 22
Page: 1086-1101
Author(s): Rüdiger Hardeland

Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes

Journal: Current Pharmaceutical Design
Volume: 22
Page: 1033-1048
Author(s): Timothy V. Beischlag, George Anderson and Gianluigi Mazzoccoli

Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)

Journal: Current Pharmaceutical Design
Volume: 22
Page: 947-948
Author(s): George Anderson

Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment

Journal: Current Alzheimer Research
Volume: 13
Page: 234-242
Author(s): Yu Chen, Hao Yan, Zaizhu Han, Yanchao Bi, Hongyan Chen, Jia Liu, Meiru Wu, Yongjun Wang and Yumei Zhang

Morphological and Functional Characteristic of Senescent Cancer Cells

Journal: Current Drug Targets
Volume: 17
Page: 377-387
Author(s): Ewa Sikora, Grazyna Mosieniak and Malgorzata Alicja Sliwinska

Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals

Journal: Current Drug Targets
Volume: 17
Page: 447-459
Author(s): Marco Malavolta, Elisa Pierpaoli, Robertina Giacconi, Laura Costarelli, Francesco Piacenza, Andrea Basso, Maurizio Cardelli and Mauro Provinciali